A comperison of Dexmedetomidine and Propofol for sedation in patients undergoing dental treatment

A comperison of Dexmedetomidine and Propofol for sedation in patients undergoing dental treatment - A comperison of Dexmedetomidine and Propofol for sedation in patients undergoing dental treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007513

Enrollment

Registered

2012-03-15

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing dental treatment

Interventions

administer propofol 0.7mg/kg for 10 minutes and then 0.5-2mg/kg/h administer dexmedetomidine 6mcg/kg for 10 minutes and then 0.2-0.6mcg/kg/h

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA1-2, Patients undergoing dental treatment in operating room under local anesthesia

Exclusion criteria

Exclusion criteria: impaired hepatic function, BMI>30, drugs affecting effect of sedatives

Design outcomes

Primary

Measure	Time frame
percutaneous oxygen saturation, time to go home, patient satisfaction	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026